Skip to main content
An official website of the United States government

imiquimod

View Patient Information
A synthetic agent with immune response modifying activity. As an immune response modifier (IRM), imiquimod stimulates cytokine production, especially interferon production, and exhibits antitumor activity, particularly against cutaneous cancers. Imiquimod's proapoptotic activity appears to be related to Bcl-2 overexpression in susceptible tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Aldara
Zyclara
Abbreviation:IMQ
Code name:R 837
S 26308
Chemical structure:1H-imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-
4-amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search